TARA
Protara Therapeutics, Inc.$4.12+0.03 (+0.73%)Prev Close$4.09·MCap$162.1M·P/E—·Vol211.1K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
11
$1.28M
◆
Net Activity
Net Seller
$1.28M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Protara Therapeutics, Inc. (TARA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 11 insider sales totaling $1.28M. The most recent insider transaction was by Shefferman Jesse (director, officer: CEO and President), who sold $882.2K worth of shares on Jul 1, 2026. Protara Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $162.1M.
TARA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Shefferman Jesse | director, officer: CEO and President | Sell | 215,687 | $4.09 | $882.2K0.6% OS | 721,832 |
| Apr 9, 2026 | Zummo Jacqueline | officer: Chief R&D Officer | Sell | 1,134 | $5.40 | $6.1K | 94,827 |
| Apr 2, 2026 | Zummo Jacqueline | officer: Chief R&D Officer | Sell | 22,598 | $5.26 | $118.9K | 95,961 |
| Jan 26, 2026 | Fabbio Patrick | Chief Financial Officer | Sell | 3,261 | $6.67 | $21.8K | 0 |
| Jan 26, 2026 | Fry Hannah | VP, Controller | Sell | 1,457 | $6.67 | $9.7K | 0 |
| Jan 26, 2026 | Shefferman Jesse | CEO and President | Sell | 8,732 | $6.67 | $58.2K | 0 |
| Jan 26, 2026 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | 3,724 | $6.67 | $24.8K | 0 |
| Jan 20, 2026 | Fabbio Patrick | Chief Financial Officer | Sell | 3,063 | $5.60 | $17.2K | 0 |
| Jan 20, 2026 | Fry Hannah | VP, Controller | Sell | 2,132 | $5.60 | $11.9K | 0 |
| Jan 20, 2026 | Shefferman Jesse | CEO and President | Sell | 16,322 | $5.60 | $91.4K | 0 |
| Jan 20, 2026 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | 6,578 | $5.60 | $36.8K | 0 |
| May 14, 2025 | Levy Richard S | Director | Buy | 20,000 | $3.19 | $63.8K | 0 |
| Mar 26, 2025 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | 21,224 | $4.53 | $96.1K | 0 |
| Sep 12, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 158,901 | $1.71 | $271.7K | 2,063,935 |
| Sep 10, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 61,992 | $1.84 | $114.3K | 2,118,935 |
| Jul 18, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 11,396 | $2.44 | $27.8K | 2,153,527 |
| Jul 11, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 74,551 | $2.36 | $175.8K | 2,207,477 |
| Jul 3, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 8,288 | $2.12 | $17.6K | 2,213,474 |
| Jun 28, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 64,568 | $2.21 | $142.5K | 2,232,256 |
| Jun 27, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 12,725 | $2.26 | $28.7K | 2,266,359 |
| May 31, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 15,054 | $2.92 | $44.0K | 114,520 |
| May 23, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 42,800 | $3.05 | $130.4K | 2,282,159 |
| May 17, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 70,885 | $3.25 | $230.3K | 2,333,044 |
| May 10, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 182,300 | $3.11 | $567.0K | 2,531,994 |
| Dec 30, 2022 | Opaleye Management Inc. | 10% Owner | Sell | 15,473 | $2.71 | $41.9K | 2,562,594 |
| Sep 15, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 23,900 | $3.93 | $93.8K | 2,575,777 |
| Aug 15, 2022 | Shefferman Jesse | CEO and President | Buy | 9,065 | $3.84 | $34.8K | 879,441 |
| Jul 5, 2022 | BESHAR LUKE M | Director | Buy | 10,000 | $3.10 | $31.0K | 198,000 |
| Apr 8, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 10,136 | $4.78 | $48.5K | 2,556,667 |
| Mar 16, 2022 | BESHAR LUKE M | Director | Buy | 10,000 | $4.25 | $42.5K | 188,000 |
| Mar 14, 2022 | BESHAR LUKE M | Director | Buy | 10,000 | $4.46 | $44.6K | 178,000 |
| Jan 31, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 24,031 | $4.96 | $119.3K | 2,550,000 |
| Dec 29, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 11,591 | $6.60 | $76.5K | 2,530,000 |
| Dec 27, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 38,000 | $6.53 | $248.3K | 2,528,409 |
| Dec 22, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 703 | $6.49 | $4.6K | 2,496,209 |
| Dec 20, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 10,353 | $6.46 | $66.9K | 2,495,506 |
| Nov 19, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 24,324 | $6.98 | $169.8K | 2,486,706 |
| Nov 8, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 6,557 | $6.50 | $42.6K | 2,464,472 |
| Jun 14, 2021 | Olivo Martin Sebastian | Chief Medical Officer | Buy | 9,893 | $10.10 | $100.0K | 14,344+222% |
TARA Insider Buying Activity
The following table shows recent insider purchases of Protara Therapeutics, Inc. (TARA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 14, 2025 | Levy Richard S | Director | Buy | 20,000 | $3.19 | $63.8K | 0 |
| Sep 15, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 23,900 | $3.93 | $93.8K | 2,575,777 |
| Aug 15, 2022 | Shefferman Jesse | CEO and President | Buy | 9,065 | $3.84 | $34.8K | 879,441 |
| Jul 5, 2022 | BESHAR LUKE M | Director | Buy | 10,000 | $3.10 | $31.0K | 198,000 |
| Apr 8, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 10,136 | $4.78 | $48.5K | 2,556,667 |
| Mar 16, 2022 | BESHAR LUKE M | Director | Buy | 10,000 | $4.25 | $42.5K | 188,000 |
| Mar 14, 2022 | BESHAR LUKE M | Director | Buy | 10,000 | $4.46 | $44.6K | 178,000 |
| Jan 31, 2022 | Opaleye Management Inc. | 10% Owner | Buy | 24,031 | $4.96 | $119.3K | 2,550,000 |
| Dec 29, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 11,591 | $6.60 | $76.5K | 2,530,000 |
| Dec 27, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 38,000 | $6.53 | $248.3K | 2,528,409 |
| Dec 22, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 703 | $6.49 | $4.6K | 2,496,209 |
| Dec 20, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 10,353 | $6.46 | $66.9K | 2,495,506 |
| Nov 19, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 24,324 | $6.98 | $169.8K | 2,486,706 |
| Nov 8, 2021 | Opaleye Management Inc. | 10% Owner | Buy | 6,557 | $6.50 | $42.6K | 2,464,472 |
| Jun 14, 2021 | Olivo Martin Sebastian | Chief Medical Officer | Buy | 9,893 | $10.10 | $100.0K | 14,344+222% |
TARA Insider Selling Activity
The following table shows recent insider sales of Protara Therapeutics, Inc. (TARA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Shefferman Jesse | director, officer: CEO and President | Sell | 215,687 | $4.09 | $882.2K0.6% OS | 721,832 |
| Apr 9, 2026 | Zummo Jacqueline | officer: Chief R&D Officer | Sell | 1,134 | $5.40 | $6.1K | 94,827 |
| Apr 2, 2026 | Zummo Jacqueline | officer: Chief R&D Officer | Sell | 22,598 | $5.26 | $118.9K | 95,961 |
| Jan 26, 2026 | Fabbio Patrick | Chief Financial Officer | Sell | 3,261 | $6.67 | $21.8K | 0 |
| Jan 26, 2026 | Fry Hannah | VP, Controller | Sell | 1,457 | $6.67 | $9.7K | 0 |
| Jan 26, 2026 | Shefferman Jesse | CEO and President | Sell | 8,732 | $6.67 | $58.2K | 0 |
| Jan 26, 2026 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | 3,724 | $6.67 | $24.8K | 0 |
| Jan 20, 2026 | Fabbio Patrick | Chief Financial Officer | Sell | 3,063 | $5.60 | $17.2K | 0 |
| Jan 20, 2026 | Fry Hannah | VP, Controller | Sell | 2,132 | $5.60 | $11.9K | 0 |
| Jan 20, 2026 | Shefferman Jesse | CEO and President | Sell | 16,322 | $5.60 | $91.4K | 0 |
| Jan 20, 2026 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | 6,578 | $5.60 | $36.8K | 0 |
| Mar 26, 2025 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | 21,224 | $4.53 | $96.1K | 0 |
| Sep 12, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 158,901 | $1.71 | $271.7K | 2,063,935 |
| Sep 10, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 61,992 | $1.84 | $114.3K | 2,118,935 |
| Jul 18, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 11,396 | $2.44 | $27.8K | 2,153,527 |
| Jul 11, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 74,551 | $2.36 | $175.8K | 2,207,477 |
| Jul 3, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 8,288 | $2.12 | $17.6K | 2,213,474 |
| Jun 28, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 64,568 | $2.21 | $142.5K | 2,232,256 |
| Jun 27, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 12,725 | $2.26 | $28.7K | 2,266,359 |
| May 31, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 15,054 | $2.92 | $44.0K | 114,520 |
| May 23, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 42,800 | $3.05 | $130.4K | 2,282,159 |
| May 17, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 70,885 | $3.25 | $230.3K | 2,333,044 |
| May 10, 2024 | Opaleye Management Inc. | 10% Owner | Sell | 182,300 | $3.11 | $567.0K | 2,531,994 |
| Dec 30, 2022 | Opaleye Management Inc. | 10% Owner | Sell | 15,473 | $2.71 | $41.9K | 2,562,594 |
TARA Insiders
Shefferman Jesse
director, officer: CEO and President
Bought $34.8KSold $1.03M
4 tradesLast: Jul 1, 2026
Similar Stocks to TARA
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B